dc.contributor.author | Coban, Eda | |
dc.contributor.author | Soysal, Aysun | |
dc.contributor.author | Atakli, Dilek | |
dc.contributor.author | Kirbas, Dursun | |
dc.date.accessioned | 2021-03-06T07:41:00Z | |
dc.date.available | 2021-03-06T07:41:00Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Coban E., Kirbas D., Atakli D., Soysal A., "Efficacy and Safety of Warfarin Experience in a Stroke Polyclinic in Stroke Patients", NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, cilt.54, ss.318-321, 2017 | |
dc.identifier.issn | 1300-0667 | |
dc.identifier.other | av_dd6bc986-9f33-4336-842a-42cbb5e0143b | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/145884 | |
dc.identifier.uri | https://doi.org/10.5152/npa.2016.15951 | |
dc.description.abstract | Introduction: Cardioembolic stroke is associated with high morbidity and mortality, with an increased risk of recurrent stroke. Oral anticoagulation is highly effective in reducing the risk of stroke and mortality compared with placebo. Our study aimed to highlight the safety and efficacy of warfarin by analyzing the 20-year follow-up of patients on warfarin therapy. | |
dc.language.iso | eng | |
dc.subject | Nöroloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | Efficacy and Safety of Warfarin Experience in a Stroke Polyclinic in Stroke Patients | |
dc.type | Makale | |
dc.relation.journal | NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 54 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 318 | |
dc.identifier.endpage | 321 | |
dc.contributor.firstauthorID | 247913 | |